India: Analysts Positive on SKS as Clarity Emerges on Capital Availability

Print
 
Oct 2012
India, October, 10 2012 - Firm seems to have restored investors' confidence, shares have gone up by more than 50% since July.

SKS Microfinance, once the largest micro-lender in the country, is gaining its lost ground as regulatory environment in the microfinance sector is improving while most of its rivals are still struggling to put the house back in order.

SKS also appears to have restored investors' confidence as its shares increased by more than 50% since July, 2012. With clarity emerging on the availability of capital following the company's qualified institutional placement (QIP) brokerages are once again recommending their clients to buy SKS stock.

After the Andhra crisis there were questions raised about SKS' survival. However, over the last six months the company has not only left the Andhra crisis behind it, but has also raised Rs 263 crore, which should enough to take care of its capital requirement for the next couple of years," Santosh Singh, analyst with Espirito Santo Securities, wrote in his note to clients today.

The brokerage has retained its 'buy' rating on the stock and expects SKS shares to touch Rs 144. It estimates over 30% growth in SKS' loan book for the next three years and sees collection efficiency improving in coming quarters. "We expect the company to start showing profits from the third of fourth quarter of this year," Singh said.



 

Research Analysis Tools

The fund indexes, institution benchmarks and other market information displayed here are all Symbiotics designed analysis tools, created in-house by our analysts and experts. Symbiotics has one of the oldest track records in microfinance investment analysis dating back to the late 1990s; its indexes and benchmarks have been regularly used as markers by investors, asset managers, financial institutions and practitioners. These, as well as several other research products, are available through the Research Account. Click on the link below to find out more.

Learn More